p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? (original) (raw)

British Journal of Cancer volume 75, pages 87–93 (1997)Cite this article

Abstract

The expression of the p53 and Rb1 proteins was examined in an unselected consecutive series of 250 primary operable colorectal carcinomas with a mean follow-up of 4.3 years (range 43-77 months). The overall cancer-specific mortality was 34.8%, with 87 cancer deaths and 35 deaths as the result of other causes. Expression of p53 protein was identified in 152 of 250 (60.8%) cases, with expression of Rb1 protein in 207 of 250 (82.8%) cases. There was no association of p53 or Rb protein expression with patient age, sex, tumour site, tumour size, tumour type, tumour grade, peritumoral fibrosis, tumour lymphocytic infiltrate, nature of the tumour margin, extramural vascular invasion, number of lymph nodes or high apical lymph node involved or local peritoneal infiltration by tumour, Dukes' stage or Jass group. There was no difference in overall survival or recurrence-free survival for those cases that showed p53 expression or Rb1 protein expression compared with those cases showing absence of p53 or Rb1 protein expression, although patients with tumours showing aberrant (reduced) Rb1 protein expression demonstrated shorter recurrence-free survival and overall survival. The effect of 'aberrant' Rb1 protein expression and shorter recurrence-free and overall survival did not, however, achieve independent statistical significance. The results from this study would suggest that expression of p53 and Rb1 proteins does not appear be useful in determining the prognosis of operable colorectal cancer.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 24 print issues and online access

$259.00 per year

only $10.79 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Histopathology and Gloucester Gastroenterology Group, Gloucestershire Royal Hospital, UK
    DN Poller

Authors

  1. DN Poller
    You can also search for this author inPubMed Google Scholar
  2. KJ Baxter
    You can also search for this author inPubMed Google Scholar
  3. NA Shepherd
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Poller, D., Baxter, K. & Shepherd, N. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer?.Br J Cancer 75, 87–93 (1997). https://doi.org/10.1038/bjc.1997.14

Download citation

This article is cited by